Mutations in a Fly Ceramide Enzyme Reveal How Sphingolipids Steer Insulin Resistance

A single mutation in a fat-body enzyme can tip the balance between metabolic resilience and insulin resistance in fruit flies, according to a new study published in BMC Biology. The research, led by Christian Vera-Granda and Reinhard Bauer at the University of Bonn together with collaborators in Münster, Düsseldorf and Potsdam, dissects how specific regions of the fly’s only ceramide synthase, a protein called Schlank, shape the body’s response to a high-sugar diet. The findings add a striking molecular layer to one of biomedicine’s most pressing questions: how the lipids inside our cells help decide whether insulin still works.

Ceramides are central intermediates of sphingolipid metabolism, a family of fatty molecules that form membranes and act as signaling compounds. In mammals, elevated ceramide levels are closely associated with insulin resistance and type 2 diabetes, but the relationship is complicated by the fact that ceramides come in many molecular species with different fatty-acid chain lengths. Ceramide synthases, the enzymes that build ceramides, therefore sit at a critical control point. Unusually, several members of the ceramide synthase family carry a conserved homeodomain, a DNA-binding module best known from transcription factors, whose metabolic role has remained poorly understood.

The fruit fly offers a clean experimental system for probing this puzzle. Drosophila melanogaster possesses only one ceramide synthase gene, schlank, whose protein contains the catalytic Lag1p motif required for ceramide production as well as two predicted nuclear localization sequences, NLS1 and NLS2, embedded within the homeodomain region. Because there is just one enzyme rather than a family of six as in mammals, any change in its sequence can be interpreted without worrying about redundancy between related proteins masking the effect.

To test what each region does, the team used genome engineering to create knock-in flies carrying precise point mutations in the endogenous schlank gene. Two variants took center stage: KINLS1, which disrupts the first nuclear localization sequence, and KIE118A, which replaces a glutamic acid at position 118 with alanine. Under normal dietary conditions both mutants looked deceptively healthy. They retained DNA binding and the transcriptional repression activity characteristic of the wild-type protein, suggesting that the homeodomain’s day job was still being performed.

The picture changed dramatically when the flies were challenged with a high-sugar diet. Both knock-in lines became markedly more vulnerable to diet-induced metabolic dysfunction, developing enhanced hyperglycemia and showing impaired recruitment of tGPH, a fluorescent reporter used to visualize insulin signaling at the cell membrane. In other words, mutations that left the enzyme’s basal functions intact still compromised the animal’s ability to cope with sugar excess, revealing that the homeodomain contributes to metabolic stress tolerance in ways invisible under standard conditions.

The KIE118A mutant displayed additional defects that pointed to a breakdown in hormonal communication. These flies showed increased nuclear localization of FoxO, a transcription factor that acts as a readout of reduced insulin signaling, and retention of DILP2, one of the fly’s insulin-like peptides, inside the insulin-producing cells of the brain. Normally these cells release DILP2 into circulation to coordinate glucose handling across the body; its accumulation within the secreting cells suggests a failure in the release machinery or in the feedback loops that normally prompt secretion.

Remarkably, the direction of the effect could be reversed depending on which part of the protein was altered and where it was expressed. When the researchers used tissue-specific allele-switching to replace the fat body’s endogenous Schlank with a DNA-binding-deficient NLS2 variant or a catalytically inactive H215D variant, selected high-sugar-diet phenotypes were partially attenuated rather than worsened. FoxO nuclear accumulation and DILP2 retention both improved in these animals. However, the rescue was incomplete: hyperglycemia and reduced body weight persisted, indicating that the fat body is one node in a larger network rather than the sole site of action.

Lipidomic analysis by mass spectrometry uncovered the biochemical substrate of these effects. The sphingolipid profile of the flies underwent extensive remodeling in a diet-dependent manner, and the two fat-body variants, NLS2 and H215D, caused a marked reduction of the fat-body ceramide pool. This depletion extended across ceramide species containing the d14:1/20:0 and d14:1/22:0 fatty-acid combinations, as well as ceramide phosphoethanolamine and hexosylceramide, the sphingolipid classes that dominate insect membranes. The data link specific ceramide species, not just total ceramide mass, to the insulin phenotypes.

The study’s central conclusion is that the Schlank homeodomain regulates insulin homeostasis in a site- and tissue-dependent manner. Disrupting the nuclear localization sequence NLS1 or the conserved glutamate at position 118 increases susceptibility to diet-induced insulin resistance, while swapping in DNA-binding-deficient or catalytically inactive variants specifically in the fat body can partially shield the animal from some of the same phenotypes. The authors propose a model in which insulin signaling, inter-organ communication between the brain’s insulin-producing cells and the fat body, and the composition of the sphingolipid pool jointly determine metabolic outcome.

For researchers working on human metabolic disease, the implications are tantalizing. Mammalian ceramide synthases also carry homeodomain-like regions, and if a comparable nuclear function exists in human cells, it could represent an unexploited regulatory axis connecting lipid metabolism, gene expression and insulin sensitivity. The fly work cannot yet prescribe therapies, but it demonstrates with unusual clarity that the same enzyme can push metabolism toward resistance or toward resilience depending on which of its molecular addresses is altered, and that the fat body, the insect analog of adipose tissue and liver, is a decisive arena in which ceramide chemistry and insulin biology meet.

Subject of Research: How homeodomain sites of the Drosophila ceramide synthase Schlank differentially regulate diet-induced insulin resistance and sphingolipid metabolism

Article Title: Drosophila CerS homeodomain sites differentially alter insulin resistance

Article References: Vera-Granda, C., Sociale, M., Beckschäfer, K., Kanevskij, I., Gerding, M., Eckardt, F., Rindsfüsser, H., Thiele, C., Ziegler, A. B., Bülow, M. H., & Bauer, R. (2026). Drosophila CerS homeodomain sites differentially alter insulin resistance. BMC Biology. https://doi.org/10.1186/s12915-026-02763-9

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02763-9

Keywords: ceramide synthase, sphingolipids, insulin resistance, Drosophila melanogaster, homeodomain, high-sugar diet, fat body, DILP2, FoxO, lipidomics, type 2 diabetes, BMC Biology